Replies to post #2152 on Galectin Therapeutics Inc. (GALT)

[JERZYATP1]

That GALT is on the right track is a view I have maintained since investing some time back. Original basis was scientific credibilty of GR-MD-02, plus intuitive positivity towards Czirr and Traber. On all counts GALT has performed well. Yes, market valuation is really low, but if GALT proves Apex, it'll be eye-opening. Good
science is often surprising.